These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8356794)

  • 1. Differences between cell membrane fusion activities of two dengue type-1 isolates reflect modifications of viral structure.
    Desprès P; Frenkiel MP; Deubel V
    Virology; 1993 Sep; 196(1):209-19. PubMed ID: 8356794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants in the envelope E protein and viral RNA helicase NS3 that influence the induction of apoptosis in response to infection with dengue type 1 virus.
    Duarte dos Santos CN; Frenkiel MP; Courageot MP; Rocha CF; Vazeille-Falcoz MC; Wien MW; Rey FA; Deubel V; Desprès P
    Virology; 2000 Sep; 274(2):292-308. PubMed ID: 10964773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
    Roehrig JT; Bolin RA; Kelly RG
    Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence.
    Hiramatsu K; Tadano M; Men R; Lai CJ
    Virology; 1996 Oct; 224(2):437-45. PubMed ID: 8874504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein.
    Lee E; Weir RC; Dalgarno L
    Virology; 1997 Jun; 232(2):281-90. PubMed ID: 9191841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein.
    Goncalvez AP; Purcell RH; Lai CJ
    J Virol; 2004 Dec; 78(23):12919-28. PubMed ID: 15542644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid changes in the recombinant Dengue 3 Envelope domain III determine its antigenicity and immunogenicity in mice.
    Zulueta A; Martín J; Hermida L; Alvarez M; Valdés I; Prado I; Chinea G; Rosario D; Guillén G; Guzmán MG
    Virus Res; 2006 Oct; 121(1):65-73. PubMed ID: 16781791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites.
    Johnson AJ; Guirakhoo F; Roehrig JT
    Virology; 1994 Sep; 203(2):241-9. PubMed ID: 8053148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH.
    Guirakhoo F; Hunt AR; Lewis JG; Roehrig JT
    Virology; 1993 May; 194(1):219-23. PubMed ID: 8480420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitopes on the dengue 1 virus envelope protein recognized by neutralizing IgM monoclonal antibodies.
    Beasley DW; Aaskov JG
    Virology; 2001 Jan; 279(2):447-58. PubMed ID: 11162801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phylogenetic relationships of dengue-2 viruses.
    Lewis JA; Chang GJ; Lanciotti RS; Kinney RM; Mayer LW; Trent DW
    Virology; 1993 Nov; 197(1):216-24. PubMed ID: 8212556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of herpes simplex virus 1 gL and anti-gL antibodies that inhibit cell fusion but not viral infectivity.
    Novotny MJ; Parish ML; Spear PG
    Virology; 1996 Jul; 221(1):1-13. PubMed ID: 8661409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence analysis of E/NS1 gene junction of dengue virus type 2 isolated in Brunei.
    Osman O; Fong MY; Devi S
    Southeast Asian J Trop Med Public Health; 2008 Jan; 39(1):62-78. PubMed ID: 18567445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of neutralizing antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors.
    Khanam S; Khanna N; Swaminathan S
    Vaccine; 2006 Oct; 24(42-43):6513-25. PubMed ID: 16860446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD; Barrett AD
    Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary study of dengue infection in Brunei.
    Osman O; Fong MY; Devi S
    Jpn J Infect Dis; 2007 Jul; 60(4):205-8. PubMed ID: 17642533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus.
    Mateu GP; Marchevsky RS; Liprandi F; Bonaldo MC; Coutinho ES; Dieudonné M; Caride E; Jabor AV; Freire MS; Galler R
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):289-98. PubMed ID: 17169387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the steps involved in Dengue virus entry into host cells.
    Hung SL; Lee PL; Chen HW; Chen LK; Kao CL; King CC
    Virology; 1999 Apr; 257(1):156-67. PubMed ID: 10208929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion.
    Butrapet S; Childers T; Moss KJ; Erb SM; Luy BE; Calvert AE; Blair CD; Roehrig JT; Huang CY
    Virology; 2011 Apr; 413(1):118-27. PubMed ID: 21353281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiological study of dengue virus type 1 in Taiwan.
    Hwang KP; Chu PY; Tung YC; Wang HL; Yueh YY; Wu YC; Chin C; Lin KH
    J Med Virol; 2003 Jul; 70(3):404-9. PubMed ID: 12767004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.